Hannelore Bax

Hannelore Bax is a Researcher at Erasmus MC, specializing in Medical Microbiology & Infectious Diseases. Her work focuses on HIV pharmacology, antibiotic efficacy, and infectious disease management. She contributes to drug development and clinical trials, particularly in tuberculosis and mycobacterial infections. Her research spans topics such as antiretroviral therapy outcomes, community-acquired pneumonia treatment, and mortality trends in HIV patients.

• Current affiliation: Erasmus MC
• Department: Medical Microbiology & Infectious Diseases

Her research interests include HIV pathogenesis, antibiotic resistance mechanisms, and novel therapeutic strategies for multidrug-resistant infections. She has collaborated on studies analyzing the efficacy of adjuvant therapies and corticosteroids in pneumonia cases.

Publications highlight her work on Mycobacterium abscessus strain variability, drug combinations (e.g., omadacycline and clofazimine), and clinical outcomes in sepsis and HIV cohorts. Her findings have been disseminated in high-impact journals like The Lancet Respiratory Medicine and Clinical Infectious Diseases.